Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3365 participants.

Also called NCT02064439

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 3,365 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02064439
  • EudraCT 2013-000619-26
Other papers using this trial's data
  • Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism The New England journal of medicine, 2017-03-30 DOI, PubMed 28316279

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Austria, Belgium, Brazil, Canada, China, Czechia, Denmark, France, Germany, Hungary, Israel, Italy, Mexico, Netherlands, New Zealand, Norway, Philippines, Poland, Russia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Türkiye, United Kingdom, Vietnam (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02064439. Randomized; quadruple masking; primary purpose prevention. Start 2014-03-05 (actual); primary completion 2016-09-22 (actual). Results posted on 2017-12-19.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)
Acronym
EinsteinChoice
Condition
Thromboembolism
Condition
Thrombosis
Condition
Venous Thrombosis
Condition
Venous Thromboembolism
Intervention (Drug)
BAY 59-7939
Intervention (Drug)
BAY 59-7939
Intervention (Drug)
ASA
Lead sponsor
Bayer (class: industry)
Collaborator
Janssen Scientific Affairs, LLC (class: industry)

Record details

Record id
cardio:ct-nct02064439
Content hash
a86e14f27bee3ee120632b76bd72d5bdd110a9a6d7aba1d7dc534bf062875557